RadNet, Inc. (RDNT)
74.69
-2.13
(-2.77%)
USD |
NASDAQ |
Aug 24, 16:00
74.67
-0.02
(-0.03%)
After-Hours: 20:00
RadNet Net Income (Quarterly) : 20.25M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.25M |
| March 31, 2026 | -24.73M |
| December 31, 2025 | 9.861M |
| September 30, 2025 | 13.89M |
| June 30, 2025 | 23.03M |
| March 31, 2025 | -29.74M |
| December 31, 2024 | 14.22M |
| September 30, 2024 | 12.26M |
| June 30, 2024 | 6.945M |
| March 31, 2024 | 5.41M |
| December 31, 2023 | 5.996M |
| September 30, 2023 | 24.07M |
| June 30, 2023 | 14.56M |
| March 31, 2023 | -14.28M |
| December 31, 2022 | 4.969M |
| September 30, 2022 | 6.447M |
| June 30, 2022 | 13.83M |
| March 31, 2022 | 8.363M |
| December 31, 2021 | 1.313M |
| September 30, 2021 | 21.14M |
| June 30, 2021 | 8.087M |
| March 31, 2021 | 13.78M |
| December 31, 2020 | 10.98M |
| September 30, 2020 | 10.22M |
| June 30, 2020 | -8.96M |
| Date | Value |
|---|---|
| March 31, 2020 | -14.00M |
| December 31, 2019 | 12.68M |
| September 30, 2019 | 5.092M |
| June 30, 2019 | 7.591M |
| March 31, 2019 | -1.922M |
| December 31, 2018 | 31.35M |
| September 30, 2018 | 5.773M |
| June 30, 2018 | 6.467M |
| March 31, 2018 | -5.454M |
| December 31, 2017 | -6.54M |
| September 30, 2017 | 3.849M |
| June 30, 2017 | 5.623M |
| March 31, 2017 | -0.86M |
| December 31, 2016 | 4.064M |
| September 30, 2016 | 1.988M |
| June 30, 2016 | 3.379M |
| March 31, 2016 | -1.107M |
| December 31, 2015 | 1.26M |
| September 30, 2015 | 8.291M |
| June 30, 2015 | 3.563M |
| March 31, 2015 | -4.476M |
| December 31, 2014 | 4.295M |
| September 30, 2014 | 4.509M |
| June 30, 2014 | 5.256M |
| March 31, 2014 | -12.38M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Castle Biosciences, Inc. | -2.06M |
| Lumexa Imaging Holdings, Inc. | 2.745M |
| Quest Diagnostics, Inc. | 333.00M |
| Labcorp Holdings, Inc. | 299.10M |
| OPKO Health, Inc. | -8.416M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 622.72M |
| Total Expenses (Quarterly) | 615.19M |
| EPS Diluted (Quarterly) | 0.0956 |
| Enterprise Value | 7.630B |
| Gross Profit Margin (Quarterly) | 7.89% |
| Profit Margin (Quarterly) | 3.25% |
| Earnings Yield | -0.37% |
| Operating Earnings Yield | 1.82% |
| Normalized Earnings Yield | -0.0185 |